Pal, et al. assessed the 10 most common TP53 missense mutations using MCF10A cell lines for preclinical investigation and found that mutations such as R248W, R273C, R248Q, and Y220C were associated with the most aggressive tumor phenotypes [73]. Here, TP53 is linked to neoplasm.